CIBC Private Wealth Group
LEGN icon

CIBC Private Wealth Group’s Legend Biotech LEGN Stock Holding History

CIBC Private Wealth Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,000
Closed -$172K – 3234
2024
Q1 		$172K Buy
+3,000
New +$181K ﹤0.01% 1187

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CIBC Private Wealth Group's LEGN Position: Q2 2024 in Review

CIBC Private Wealth Group sold out of Legend Biotech (LEGN) in Q2 2024, closing a stake of 3,000 shares — an estimated $172K sold.

CIBC Private Wealth Group first reported a position in LEGN in Q1 2024 and held it in 1 quarter. The position peaked at $172K in Q1 2024. 181 funds tracked by Wall St. Rank hold LEGN as of Q2 2024.

  • CIBC Private Wealth Group reported no remaining Legend Biotech position as of Q2 2024 after selling out during the quarter.
  • CIBC Private Wealth Group sold 3,000 Legend Biotech shares in Q2 2024, an estimated $172K.
  • CIBC Private Wealth Group first reported a position in Legend Biotech in Q1 2024 and held it in 1 quarter.
  • CIBC Private Wealth Group's Legend Biotech position peaked at $172K in Q1 2024.
  • 181 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2024.

Based on CIBC Private Wealth Group's 13F filing for Q2 2024, filed 9 Aug 2024.